Literature DB >> 8651180

Giant gastric ulceration associated with antiphospholipid antibody syndrome.

D R Kalman1, A Khan, P L Romain, D J Nompleggi.   

Abstract

The anticardiolipin or antiphospholipid antibody syndrome is characterized by an increased incidence of venous and arterial thromboses. This syndrome may occur in association with systemic lupus erythematosus or independently. Gastroenterological manifestations have included Budd-Chiari syndrome, hepatic infarction, esophageal necrosis with perforation, intestinal ischemia and infarction, pancreatitis, and colonic ulceration. We report a 39-yr-old man with antiphospholipid antibody syndrome complicated by adrenal insufficiency secondary to bilateral adrenal infarction who presented with severe epigastric pain. Endoscopic evaluation disclosed progressive gastric ulceration with necrosis in the distal body. Angiography revealed no vasculitis. Because of intractable pain despite intravenous anticoagulation and narcotic analgesia, the patient was taken to surgery, and an antrectomy with Billroth II gastrojejunostomy was performed. Histological examination revealed widespread vascular occlusive disease involving veins, small arteries, and arterioles present in all layers of the stomach and the perigastric fat consistent with the vasculopathy of the antiphospholipid antibody syndrome. Treatment with high intensity oral anticoagulation and corticosteroids resulted in clinical and endoscopic improvement. This case report extends the gastroenterological manifestations of the antiphospholipid antibody syndrome to include giant gastric ulceration and emphasizes the importance of anticoagulation in treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8651180

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

2.  Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome.

Authors:  Tatiana M Reshetnyak; Natalia V Seredavkina; Maria A Satybaldyeva; Evgeniy L Nasonov; Vasiliy I Reshetnyak
Journal:  World J Hepatol       Date:  2015-09-08

Review 3.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 4.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

5.  Massive gangrene of the stomach due to primary antiphospholipid syndrome: report of two cases.

Authors:  Vivek Srivastava; Somprakas Basu; Mumtaz Ansari; Saroj Gupta; Anand Kumar
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

Review 6.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

7.  Conservative management of gastric pneumatosis following left gastric artery embolisation.

Authors:  Matthew D Bloom; Michael Ladna
Journal:  BMJ Case Rep       Date:  2022-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.